Provided by Tiger Fintech (Singapore) Pte. Ltd.

NanoVibronix Inc

7.16
-0.1800-2.45%
Post-market: 7.210.0487+0.68%19:52 EDT
Volume:97.53K
Turnover:710.91K
Market Cap:5.44M
PE:-0.52
High:7.55
Open:7.50
Low:7.05
Close:7.34
Loading ...

Nanovibronix Regains Nasdaq Compliance

Reuters
·
11 Apr

Dow Jumps Over 1,100 Points; US Small Business Sentiment Falls In March

Benzinga
·
08 Apr

Nanovibronix Announces Renewal and Expansion of Distribution Agreement With Dukehill Healthcare Pty Ltd in Australia

THOMSON REUTERS
·
01 Apr

Nanovibronix Inc - Expansion of Agreement With Dukehill NOW Extends to All Australian States

THOMSON REUTERS
·
01 Apr

NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia

Business Wire
·
01 Apr

Why Nanovibronix Inc. (NAOV) Surged On Thursday?

Insider Monkey
·
21 Mar

Top Premarket Gainers

MT Newswires Live
·
17 Mar

Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal

Business Wire
·
14 Mar

NanoVibronix Inc trading halted, news pending

TIPRANKS
·
14 Mar

NanoVibronix Completes ENvue Medical Acquisition

MT Newswires Live
·
14 Feb

NanoVibronix completes acquisition of ENvue Medical

TIPRANKS
·
14 Feb

Nanovibronix, Inc. Announces Acquisition of Envue Medical Holdings, Corp.

THOMSON REUTERS
·
14 Feb

NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.

Business Wire
·
14 Feb

BRIEF-Nanovibronix Advances Development Of Painshield And Uroshield With Completion Of Nextgen Prototypes

Reuters
·
07 Jan

Nanovibronix Advances Development of Painshield and Uroshield With Completion of Nextgen Prototypes

THOMSON REUTERS
·
07 Jan

BRIEF-Nanovibronix Completes Pilot Phase Of Clinical Study Of Uroshield At The University Of Michigan

Reuters
·
06 Jan

Nanovibronix Announces Completion of Pilot Phase of Clinical Study of Uroshield® at the University of Michigan

THOMSON REUTERS
·
06 Jan

NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan

Business Wire
·
06 Jan

NanoVibronix gets $12M purchase deal for PainShield, extends distribution pact

TIPRANKS
·
11 Dec 2024

Nanovibronix Secures $12 Million Minimum Purchase Commitment for Painshield With Extension of Distribution Agreement

THOMSON REUTERS
·
11 Dec 2024